Related Experiment Video
Updated: Jun 26, 2026

Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
Symptomatic intracranial stenosis: best medical treatment vs. intracranial stenting
1Oregon Health and Science University and Oregon Stroke Center, Portland, Oregon 97239-3098, USA. lutseph@ohsu.edu
Insights
Endovascular stenting may benefit patients with severe symptomatic intracranial stenosis (70-99%) at high risk of stroke. Ongoing trials are evaluating stenting versus medical therapy for these patients.
Area of Science:
- Neurology
- Interventional Cardiology
- Vascular Surgery
Background:
- Symptomatic intracranial stenosis poses a high risk of stroke and mortality.
- Medical therapy alone has limitations in preventing vascular events.
- Endovascular treatment is being explored as an alternative approach.
Purpose of the Study:
- To review current endovascular treatment options for symptomatic intracranial stenosis.
- To evaluate the efficacy and safety of stenting in this patient population.
- To identify patient subgroups most likely to benefit from stenting.
Main Methods:
- Review of clinical trials and prospective registries evaluating stent systems for intracranial stenosis.
- Analysis of data from studies on Wingspan and Neurolink Stent Systems.
- Assessment of ongoing randomized controlled trials comparing stenting with medical therapy.
Main Results:
- Three stent designs exist for intracranial stenosis treatment.
- Wingspan and Neurolink Stent Systems have undergone single-arm trials.
- Evidence suggests stenting is most beneficial for patients with 70-99% stenosis at high risk of stroke.
Conclusions:
- Randomized trials are needed to compare stenting with medical therapy in high-risk patients.
- Ongoing trials are investigating optimal treatment strategies for symptomatic intracranial stenosis.
- Further research is assessing medical therapies, including cilostazol, in managing intracranial stenosis.
Purpose Of Review:
The high risk of stroke and death in patients with symptomatic intracranial stenosis despite medical therapy has spurred interest in endovascular treatment approaches.
Recent Findings:
Three stents have been designed for the treatment of intracranial stenosis, and two, the Wingspan and Neurolink Stent Systems, have been evaluated in single-arm trials. The trials and two prospective registries evaluating the Wingspan Stent System suggest that stenting is most likely to be beneficial in patients with the highest risk of stroke on medical therapy, namely those with 70-99% stenosis.
Summary:
Randomized treatment trials comparing stenting with medical therapy in symptomatic intracranial stenosis need to target the patients at highest risk of recurrent vascular events on medical therapy. Such trials are in progress. Ongoing trials in Asia are also assessing medical therapies, including cilostazol, in patients with intracranial stenosis.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aneurysm III: Interprofessional Care
Angle Closure Glaucoma: Treatment
